We came across a bullish thesis on Cencora, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on COR. Cencora, Inc.’s share was trading at $292.67 as of July 21st. COR’s trailing and forward P/E were 33.87 and 16.81, respectively according to Yahoo Finance.
A closeup view of a magnified pharmaceutical tablet.
Cencora, Inc. stands as a critical pillar of the healthcare ecosystem, operating as one of the world’s largest pharmaceutical...
